Bio Medica Laboratories IPO Details, Review & Analysis 2026
The Bio Medica Laboratories IPO is an upcoming SME book-building issue set to be listed on the NSE SME platform, offering a mix of fresh equity shares and an offer for sale totaling around 37.71 lakh shares. The company operates in the pharmaceutical sector, specializing in the manufacturing of parenteral formulations such as liquid and dry powder injectables used for both human and veterinary healthcare. It follows a B2B contract manufacturing model, supplying generic, ethical, and OTC drugs to various pharmaceutical companies.